Onconetix, Inc. (ONCO) stock
ONCONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.05 (-10.13%)
Close on Oct 19, 2026Market cap $965.06KP/E –Yield –
Onconetix free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Onconetix's free cash flow for the twelve months ending Dec 31, 2024 was -$10.52M. For fiscal 2024 it was -$10.52M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$10.52M | – |
| FY2023 | Dec 31, 2023 | -$13.58M | – |
| FY2022 | Dec 31, 2022 | -$8.68M | – |
| FY2021 | Dec 31, 2021 | -$2.05M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -$921.52K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.15M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.24M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.31M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.04M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.80M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.81M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$891.29K | – |
See a number that looks wrong?